10x Insights
Loading account…

JNL/T. Rowe Price Capital Appreciation Fund

Actively managedAllocation (multi-asset)Open-end fund
JNL Series TrustHoldings as of Jun 30, 2026Filed Aug 26, 2026

Aggressive allocation fund

2026 Q2 holdings and allocationChanges are against the previous quarter, 2026 Q1
Expense ratio
0.67%
$67 a year for every $10,000 invested
0.67% – 0.97% across the 2 classes
$15.30B
The whole fund, all share classes
171 holdings
30.1%in the top 10
Weight held in the ten largest holdings
Top 25 hold 55.7%
Return, 1 year
+14.9%
With dividends, to Apr 2026
3 yr total +42.5% · 5 yr total +47.4%
What this fund is
Objective, as filed

The investment objective of the Fund is to seek long-term capital appreciation by investing primarily in common stocks. It may also hold fixed income and other securities to help preserve principal value.

Strategy, summarised

The fund is managed by T. Rowe Price Associates as sub-adviser and invests at least 50% of assets in common stocks selected for low valuations relative to assets, earnings, or other measures, alongside a smaller allocation to opportunistic positions expected to appreciate near-term. The remainder is held in corporate and government debt, mortgage- and asset-backed securities, and bank loans, with up to 25% in foreign securities and no more than 30% in below-investment-grade debt and bank loans combined. Because security selection depends on the sub-adviser's identification of undervalued companies and attractive risk-reward opportunities, fund performance will diverge from broad market returns. The sub-adviser may establish relatively large positions in favored companies and concentrate significantly in particular sectors.

What you own

per cent of the fund
CompanyWeightValue
TRPGRIAT. Rowe Price Government Reserve Fund
4.48%
$686.07M
3.55%
$543.38M
3.50%
$535.40M
2.99%
$457.02M
2.78%
$425.80M
2.69%
$410.96M
2.67%
$408.61M
2.65%
$405.19M
Treasury, United States Department of
3.50% · due 2031-02-28
2.50%
$382.35M
2.33%
$356.47M
Showing 1–10 of 171 · the top 10 are 30.14% of the fund, the top 25 are 55.69%

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

All 171 holdings, with the share counts as filed, open with a free account.

What the fund is made of

Percentages are of fund net assets. Rounding, liabilities and short positions can make totals differ from 100%.

99.68%
of net assets
Stocks63.47%
Bonds23.66%
Loans8.48%
Cash & short-term4.58%
Securitized0.04%
Derivatives-0.55%

The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.

Derivatives are shown at market value, not notional exposure.

By sector

Information Technology
18.8%
Government
15.4%
Other
13.1%
Health Care
10.6%
11 other sectors
42.1%

How it has done

Total return, dividends reinvested · to Apr 2026

C000218188 share class · total returns with dividends reinvested

1 year
+14.86%
3 years
+42.54%
Cumulative, not per year
5 years
+47.43%
Cumulative, not per year
Largest decline in 3 years
-5.71%
From a previous high to a later low
Cumulative return, last three years· Jul 2023 – Apr 2026

Volatility over the last 12 months: 8.85%. Past returns are a record, not a forecast.

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.

Fees & fund details

JNL/T. Rowe Price Capital Appreciation Fund is an aggressive allocation fund. 19% of JNL/T. Rowe Price Capital Appreciation Fund ’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 90% of the fund’s equity).

Asset class
Allocation (multi-asset)
Region
United States
Management
Actively managed
Fund type
Open-end fund
Equity exposure
Aggressive
Expense ratio, by class
0.67%0.97%
Portfolio turnover
124.00% a year · as of 2026 Q2

Turnover is how much of the portfolio was replaced in a year.

Classified from what the fund holds, not from its name · 2026 Q2. The summary is a paraphrase of the prospectus; the objective is verbatim.

What changed this quarter

2026 Q2 vs 2026 Q1

Positions that entered or left the fund since its previous filing. Positions that were only resized are not listed.

29 new· the largest 7

Treasury, United States Department of
2 holdings
Ascendis Pharma A/S
ASML Holding N.V.

22 exited· the largest 8

Treasury, United States Department of
Ascendis Pharma A/S
Broadstreet Partners, Inc.
BioNTech SE

Debt profile

What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-06-30

Avg coupon
4.94%
Avg maturity
6.30 yr
Coupon type

Share of the fund's debt by how its coupon behaves — the fact that decides whether a rate move reaches this portfolio at all.

26%
floating
Fixed rate73.6%
Floating rate26.4%
Maturity ladder

Share of the fund's debt value in each maturity band, shortest first.

<1y10y+
<1y1.5%
1-3y5.0%
3-5y55.4%
5-10y32.5%
10y+5.6%
Flagged holdings
Defaulted: none reported
In arrears: none reported
Paid in kind: none reported

Based on what filers reported; a filer that never reported a flag also reads as none.

Risk profile

Interest-rate and credit-spread sensitivity, both in years · as of 2026Q2

Most of this fund’s sensitivity is to interest rates, with credit spreads carrying about half as much.

1.02 yr
approx. move per 100bp
0.60 yr
approx. move per 100bp
If rates and spreads both rise 100bp

Where the loss would come from. The two shocks are the same size, so this is the balance of the fund's two sensitivities rather than a bet on one moving more.

≈ -1.5%
of value
Interest rates63%
Credit spreads37%

Filers report the impact of a 0.01% move only, so the total is our own scaling of that one number and overstates the loss on most bonds — read it as approximate, never as precise. The two sensitivities overlap rather than add up: they measure the same positions against different shocks, which is why the durations above are shown side by side and never summed.

Credit risk by quality

Share of the fund's spread duration carried by each credit tier.

+0.60
yrs total
High yield+0.48 yr
Investment grade+0.13 yr
Where the risk sits on the curve

Share of duration at each point, shortest first. A positive figure loses value when spreads widen; a negative one offsets — a credit hedge.

Interest rate1.02 yr total
3 mo30 yr
3 mo0.00 yr0%
1 yr0.07 yr7%
5 yr0.70 yr68%
10 yr0.16 yr16%
30 yr0.09 yr9%
Credit spread0.60 yr total
3 mo30 yr
3 mo0.00 yr0%
1 yr0.07 yr12%
5 yr0.39 yr64%
10 yr0.05 yr9%
30 yr0.09 yr15%

The two bands measure the same positions against different shocks and do not add — a Treasury carries rate duration and no spread duration, a floating-rate credit the reverse. Rate tenors are also summed across every currency the fund discloses.

Show the numbers
TenorRate yrsIG yrsHY yrsIG $/bpHY $/bp
3 mo+0.00+0.00+0.00$669$634
1 yr+0.07+0.01+0.07$11.2k$100.3k
5 yr+0.70+0.03+0.36$39.6k$552.9k
10 yr+0.16+0.01+0.04$14.6k$68.5k
30 yr+0.09+0.08+0.00$129.9k$6.4k

Dollar change per 1bp of spread movement, as filed and sign-anchored. A blank cell was not filed; a zero was.

Connected research

Understand how this fund fits with the rest.

Explore shared holdings, compare funds and follow their businesses with your connected AI:

  • Where do my funds overlap — this fund, QQQ and the fund in my 401(k)?
  • How do this fund’s ten biggest holdings stack up against each other?
  • For my target-date fund, what’s the real stock-and-bond mix once you look through it?
See how it works →All research tools with a subscription. Use your own AI account.